DIGIK Competitors

Sotrender is a social media analytics software that helps marketers: 🚀 Analyse current performance and ongoing campaigns (paid and organic) 🚀 Track competitors and uncover their strategy 🚀 Automate the process of generating summary reports 🚀 Optimise their social media performance and marketing strategy You’ll no longer need to worry about missing out on important insights - Sotrender automatically collects all your historical data, and you can dig deeper into them at a time that suits you. Here are other benefits of using Sotrender: 🟣 Cut down the time it takes to prepare a report each month. Generate a white-labeled report within minutes so you’ll have more time to focus on creative tasks. 🟣 Understand your, and your competitors, content performance, audience preferences, and behaviors. 🟣 Keep an eye on all your KPIs and monitor if you’re getting closer to achieving set goals. 🟣 Manage and organize online conversations smoothly with Sotrender’s Social Inbox. Take advantage of the 7-day free trial and build a better social media presence for your brand. ✨ 📨 Contact us: contact@sotrender.com 💻 Learn more: www.sotrender.com/blog

CodeControl works with the top developers, designers and product managers in Europe. Together with this community of tech talent, we match companies & projects with top talent - within 24hours. Whether you need a quick and effective MVP or plan to undertake a large-scale project spanning many years, we can help you create kick-ass digital products. Need someone to manage the project from start-to-finish? Then we assemble you a complete team. Or we provide dedicated resources that work directly with you (on-site or remotely) for as long as needed. We also have extensive experience in tech due diligences, code reviews, and tech interviews. Ready to streamline your software development? Then we can't wait to hear from you - hello@codecontrol.io

Plexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of Monovalent Direct Degraders and Molecular Glues. Our small molecule compounds are being developed as potential first-in-class and best-in-class treatments for high unmet medical needs. Our pipeline is powered by our DELTA Discovery™ platform, including a proprietary ultra-high throughput (uHTS) cell-based screening capability that has supported the advancement of multiple clinical-stage protein degraders. We leverage a suite of enabling technologies that expand the “druggable” target space for TPD and beyond.